MTD vs BIO stock comparison
Mettler Toledo International vs. Bio-rad Laboratories · data as of November 13, 2026
Mettler Toledo International (MTD) has a market value of about $34.6B, Bio-rad Laboratories (BIO) about $9.9B. Over their latest twelve months Mettler Toledo International had revenue of $4.2B and Bio-rad Laboratories $2.6B.
On our five checks Bio-rad Laboratories scores higher: 2.2 out of 5 (weak) against 1.6 (weak).
By area, the stronger company is Bio-rad Laboratories on value; Bio-rad Laboratories on future growth; Mettler Toledo International on track record; Bio-rad Laboratories on financial health.
Bio-rad Laboratories is cheaper on earnings (P/E 9.7 vs. 37.7), while Mettler Toledo International grew revenue faster over five years (5.5% vs. 0.3% a year).
Mettler Toledo International leads on 10 of the compared lines and Bio-rad Laboratories on 11.
Side by side
| MTD | BIO | |
|---|---|---|
| Size and price | ||
| Market cap | $34.6B | $9.9B |
| Share price | $1,738.91 | $366.36 |
| Score | ||
| Overall score (of 5) | 1.6 | 2.2 |
| Value | 0 | 2 |
| Future growth | 1 | 3 |
| Track record | 2 | 0 |
| Financial health | 2 | 3 |
| Shareholder returns | 3 | 3 |
| Valuation | ||
| P/E (TTM) | 37.7 | 9.7 |
| Forward P/E | 33.6 | 34.5 |
| Price / free cash flow | 39.7 | 29.9 |
| Price / sales | 8.2 | 3.8 |
| EV / EBITDA | 28.7 | 92.3 |
| PEG | 3.42 | — |
| DCF value vs. price | −49% | −62% |
| Business | ||
| Revenue | $4.2B | $2.6B |
| Net income | $934M | $1.0B |
| Free cash flow | $871M | $329M |
| Net margin | 22.2% | 39.5% |
| Gross margin (5-yr avg.) | 59.2% | 54.2% |
| ROIC (5-yr avg.) | — | 2.4% |
| Growth | ||
| Revenue growth (1 yr) | 4.0% | 0.7% |
| Revenue growth (5 yrs, per year) | 5.5% | 0.3% |
| EPS growth (5 yrs, per year) | 11.0% | -26.1% |
| Balance sheet and payouts | ||
| Net cash (cash minus debt) | -$2.0B | $301M |
| Dividend yield | None | None |
| Shareholder yield | 2.3% | 3.0% |
| Analysts | ||
| Upside to average target | −0% | −3% |
| Consensus rating | Hold | Hold |
Highlighted = the better figure on that line. Revenue, net income and free cash flow: MTD TTM to September 30, 2026, BIO TTM to September 30, 2026. Not investment advice.
Frequently asked questions
Which is the better stock, Mettler Toledo International or Bio-rad Laboratories?
We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Bio-rad Laboratories scores 2.2 out of 5 and Mettler Toledo International 1.6; the table shows where each one is stronger.
Is Mettler Toledo International cheaper than Bio-rad Laboratories?
On trailing earnings, Bio-rad Laboratories trades at a P/E of 9.7 and Mettler Toledo International at 37.7, so Bio-rad Laboratories is cheaper by this measure. A lower P/E can also reflect slower expected growth.
Which grows faster, Mettler Toledo International or Bio-rad Laboratories?
Over five years Mettler Toledo International grew revenue about 5.5% a year and Bio-rad Laboratories about 0.3% a year.
Full Mettler Toledo International analysis → Full Bio-rad Laboratories analysis →
More comparisons
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.